Economy13 November 20263 min read
NITI Aayog finds PLI schemes raise output but lag on employment targets
NITI Aayog, with IIM Ahmedabad as its knowledge partner, has released a mid-course assessment of Production Linked Incentive (PLI) schemes across 14 sectors. By March 2026, the schemes had recorded ₹2.40 lakh crore in investment and ₹22.66 lakh crore in production and sales.
Launched in 2020 under Atmanirbhar Bharat, the schemes initially covered three sectors and were later expanded to 14. They offer eligible manufacturers incentives linked to performance, including incremental sales and prescribed investment and production conditions. Their approved outlay is ₹1,91,049 crore.
Investment and production outpace employment
Investment had reached 76% of its full-tenure target of ₹3.15 lakh crore, while production and sales stood at 64% of the target of ₹35.37 lakh crore. Employment reached 8.49 lakh jobs, or 28% of its target of 30.19 lakh, even though 58% of the schemes’ combined implementation period had elapsed. Incentive disbursement was ₹35,354 crore, or 18.51% of the outlay. Payments are made after firms meet eligibility conditions, rather than upfront.
The assessment said nearly 70% of targeted segments were broadly on track, but results varied across sectors. It attributed the employment lag partly to the time needed to commission capacity, ramp up production and expand commercially. High capital intensity and automation also limit job creation in some sectors.
The Large Scale Electronics Manufacturing scheme was identified as efficient in resource use and output generation. Mobile exports under the scheme had risen nearly nine-fold to ₹2 lakh crore in FY2025, while imports fell 77%. The Pharmaceutical PLI scheme attracted more than ₹45,000 crore in investment through 55 approved applicants and enabled first-time domestic production of 191 pharmaceutical products. The Bulk Drugs PLI scheme created 55,000 MT of capacity across 26 critical active pharmaceutical ingredients. The sector moved from a ₹1,930 crore trade deficit in FY2021–22 to a ₹2,280 crore surplus in FY2024–25.
Progress in other areas has faced different constraints. High investment and turnover thresholds can restrict smaller firms, particularly in textiles. Reliance on imported components and raw materials limits domestic value addition, while technology gaps and long gestation periods slow some sectors. The Advanced Chemistry Cell battery scheme, for instance, has faced delays linked to localisation norms, long gestation, technology gaps and dependence on critical minerals.
Assessment calls for sector-specific measures
NITI Aayog recommends interventions tailored to sectoral differences in technology, capital needs and gestation periods, instead of a uniform approach. It calls for balancing supply-side incentives with demand-side measures such as domestic procurement, stronger domestic consumption and export-market development. The assessment also recommends standardised monitoring of investment, production, employment, exports and additional revenue, including at firm level, and closer coordination between the Centre and States to address regulatory and implementation barriers.
It also calls for better access to finance, technology, infrastructure and quality certification, and for rationalising eligibility conditions where needed to widen MSME participation.